Literature DB >> 30171279

Global trends in diabetes complications: a review of current evidence.

Jessica L Harding1, Meda E Pavkov2, Dianna J Magliano3,4, Jonathan E Shaw3, Edward W Gregg2.   

Abstract

In recent decades, large increases in diabetes prevalence have been demonstrated in virtually all regions of the world. The increase in the number of people with diabetes or with a longer duration of diabetes is likely to alter the disease profile in many populations around the globe, particularly due to a higher incidence of diabetes-specific complications, such as kidney failure and peripheral arterial disease. The epidemiology of other conditions frequently associated with diabetes, including infections and cardiovascular disease, may also change, with direct effects on quality of life, demands on health services and economic costs. The current understanding of the international burden of and variation in diabetes-related complications is poor. The available data suggest that rates of myocardial infarction, stroke and amputation are decreasing among people with diabetes, in parallel with declining mortality. However, these data predominantly come from studies in only a few high-income countries. Trends in other complications of diabetes, such as end-stage renal disease, retinopathy and cancer, are less well explored. In this review, we synthesise data from population-based studies on trends in diabetes complications, with the objectives of: (1) characterising recent and long-term trends in diabetes-related complications; (2) describing regional variation in the excess risk of complications, where possible; and (3) identifying and prioritising gaps for future surveillance and study.

Entities:  

Keywords:  Complications (all); Epidemiology; Review; Trends

Mesh:

Year:  2018        PMID: 30171279     DOI: 10.1007/s00125-018-4711-2

Source DB:  PubMed          Journal:  Diabetologia        ISSN: 0012-186X            Impact factor:   10.122


  69 in total

1.  Recent trends in cardiovascular complications among men and women with and without diabetes.

Authors:  Gillian L Booth; Moira K Kapral; Kinwah Fung; Jack V Tu
Journal:  Diabetes Care       Date:  2006-01       Impact factor: 19.112

2.  Declining Trends of Cardiovascular-Renal Complications and Mortality in Type 2 Diabetes: The Hong Kong Diabetes Database.

Authors:  Andrea O Y Luk; Eric M T Hui; Ming-Chuen Sin; Chun-Yip Yeung; Wing-Sun Chow; Andrew Y Y Ho; Hin-Fai Hung; Eva Kan; Chiu-Ming Ng; Wing-Yee So; Chi-Kin Yeung; Kin-Sang Chan; Kin-Wah Chan; Pang-Fai Chan; Shing-Chung Siu; Sau-Cheung Tiu; Vincent T F Yeung; Juliana C N Chan; Frank W K Chan; Clement Cheung; Ngai-Tseung Cheung; Siu-Tung Ho; Karen S L Lam; Linda W L Yu; David Chao; Ip-Tim Lau
Journal:  Diabetes Care       Date:  2017-05-10       Impact factor: 19.112

3.  Doubly disabled: diabetes in combination with an eating disorder.

Authors:  A Ward; N Troop; M Cachia; P Watkins; J Treasure
Journal:  Postgrad Med J       Date:  1995-09       Impact factor: 2.401

4.  A longitudinal study of affective and anxiety disorders, depressive affect and diabetes distress in adults with Type 2 diabetes.

Authors:  L Fisher; M M Skaff; J T Mullan; P Arean; R Glasgow; U Masharani
Journal:  Diabet Med       Date:  2008-09       Impact factor: 4.359

5.  Diabetes mellitus in people with schizophrenia, bipolar disorder and major depressive disorder: a systematic review and large scale meta-analysis.

Authors:  Davy Vancampfort; Christoph U Correll; Britta Galling; Michel Probst; Marc De Hert; Philip B Ward; Simon Rosenbaum; Fiona Gaughran; John Lally; Brendon Stubbs
Journal:  World Psychiatry       Date:  2016-06       Impact factor: 49.548

6.  All-cause and cardiovascular mortality in middle-aged people with type 2 diabetes compared with people without diabetes in a large U.K. primary care database.

Authors:  Kathryn S Taylor; Carl J Heneghan; Andrew J Farmer; Alice M Fuller; Amanda I Adler; Jeffrey K Aronson; Richard J Stevens
Journal:  Diabetes Care       Date:  2013-02-22       Impact factor: 19.112

7.  Time Trends in Ischemic Stroke among Type 2 Diabetic and Non-Diabetic Patients: Analysis of the Spanish National Hospital Discharge Data (2003-2012).

Authors:  Nuria Muñoz-Rivas; Manuel Méndez-Bailón; Valentín Hernández-Barrera; José Ma de Miguel-Yanes; Rodrigo Jiménez-García; Jesús Esteban-Hernández; Isabel Jiménez-Trujillo; Alejandro Alvaro-Meca; Pilar Carrasco-Garrido; Javier de Miguel-Díez; Ana López-de-Andrés
Journal:  PLoS One       Date:  2015-12-29       Impact factor: 3.240

8.  Vital Signs: Decrease in Incidence of Diabetes-Related End-Stage Renal Disease among American Indians/Alaska Natives - United States, 1996-2013.

Authors:  Ann Bullock; Nilka Ríos Burrows; Andrew S Narva; Karen Sheff; Israel Hora; Akaki Lekiachvili; Hannah Cain; David Espey
Journal:  MMWR Morb Mortal Wkly Rep       Date:  2017-01-13       Impact factor: 17.586

9.  Incidence, morbidity, mortality, and prevalence of diabetes in Denmark, 2000-2011: results from the Diabetes Impact Study 2013.

Authors:  Anders Green; Camilla Sortsø; Peter Bjødstrup Jensen; Martha Emneus
Journal:  Clin Epidemiol       Date:  2015-10-23       Impact factor: 4.790

10.  Trends in type 2 diabetes incidence and mortality in Scotland between 2004 and 2013.

Authors:  Stephanie H Read; Joannes J Kerssens; David A McAllister; Helen M Colhoun; Colin M Fischbacher; Robert S Lindsay; Rory J McCrimmon; John A McKnight; John R Petrie; Naveed Sattar; Sarah H Wild
Journal:  Diabetologia       Date:  2016-07-28       Impact factor: 10.122

View more
  206 in total

Review 1.  From glucose lowering agents to disease/diabetes modifying drugs: a "SIMPLE" approach for the treatment of type 2 diabetes.

Authors:  Ofri Mosenzon; Stefano Del Prato; Meir Schechter; Lawrence A Leiter; Antonio Ceriello; Ralph A DeFronzo; Itamar Raz
Journal:  Cardiovasc Diabetol       Date:  2021-04-28       Impact factor: 9.951

2.  Trends in cancer mortality among people with vs without diabetes in the USA, 1988-2015.

Authors:  Jessica L Harding; Linda J Andes; Edward W Gregg; Yiling J Cheng; Hannah K Weir; Kai M Bullard; Nilka Ríos Burrows; Giuseppina Imperatore
Journal:  Diabetologia       Date:  2019-09-12       Impact factor: 10.122

3.  The Cross-Talk Between Atopic Dermatitis and Diabetes Mellitus: A Meta-Analysis.

Authors:  Hyder O Mirghani; Khalid Alhazmi; Salah Alghamdi; Mohammed Alraddadi
Journal:  Cureus       Date:  2021-03-07

Review 4.  Incretin drugs in diabetic kidney disease: biological mechanisms and clinical evidence.

Authors:  Radica Z Alicic; Emily J Cox; Joshua J Neumiller; Katherine R Tuttle
Journal:  Nat Rev Nephrol       Date:  2020-11-20       Impact factor: 28.314

5.  Secular trends in all-cause and cause-specific mortality rates in people with diabetes in Hong Kong, 2001-2016: a retrospective cohort study.

Authors:  Hongjiang Wu; Eric S H Lau; Ronald C W Ma; Alice P S Kong; Sarah H Wild; William Goggins; Elaine Chow; Wing-Yee So; Juliana C N Chan; Andrea O Y Luk
Journal:  Diabetologia       Date:  2020-01-16       Impact factor: 10.122

6.  Celecoxib ameliorates diabetic neuropathy by decreasing apoptosis and oxidative stress in dorsal root ganglion neurons via the miR-155/COX-2 axis.

Authors:  Xiaoliang Cheng; Ling Zhao; Tingyu Ke; Xi Wang; Lijun Cao; Shuyan Liu; Jie He; Wei Rong
Journal:  Exp Ther Med       Date:  2021-06-02       Impact factor: 2.447

7.  Skin intrinsic fluorescence scores are a predictor of all-cause mortality risk in type 1 diabetes: The Epidemiology of Diabetes Complications study.

Authors:  Erin L Tomaszewski; Trevor J Orchard; Marquis Hawkins; Baqiyyah N Conway; Jeanine M Buchanich; John Maynard; Thomas Songer; Tina Costacou
Journal:  J Diabetes Complications       Date:  2020-10-23       Impact factor: 2.852

Review 8.  Young-onset type 2 diabetes mellitus - implications for morbidity and mortality.

Authors:  Dianna J Magliano; Julian W Sacre; Jessica L Harding; Edward W Gregg; Paul Z Zimmet; Jonathan E Shaw
Journal:  Nat Rev Endocrinol       Date:  2020-03-20       Impact factor: 43.330

9.  The impact of hospital-diagnosed depression or use of antidepressants on treatment initiation, adherence and HbA1c/LDL target achievement in newly diagnosed type 2 diabetes.

Authors:  Christopher Rohde; Jakob S Knudsen; Norbert Schmitz; Søren Dinesen Østergaard; Reimar W Thomsen
Journal:  Diabetologia       Date:  2020-10-19       Impact factor: 10.122

10.  Association of dietary intake, medication and anthropometric indices with serum levels of advanced glycation end products, caspase-3, and matrix metalloproteinase-9 in diabetic patients.

Authors:  Elaheh Foroumandi; Sorayya Kheirouri; Rahmat Nosrati; Ramin Ghodsi
Journal:  J Diabetes Metab Disord       Date:  2021-05-02
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.